Literature DB >> 20551133

ViewDock TDW: high-throughput visualization of virtual screening results.

Christopher D Lau1, Marshall J Levesque, Shu Chien, Susumu Date, Jason H Haga.   

Abstract

SUMMARY: ViewDock TDW is a modification of the pre-existing ViewDock Chimera extension (http://www.cgl.ucsf.edu/chimera/) used to visualize results of virtual screening experiments. By combing TDW hardware and an enhanced ViewDock interface, dozens of ligand-protein complexes are rendered simultaneously to parallelize the analysis of candidate ligands. The ViewDock TDW GUI allows the user to easily and interactively manipulate the molecules on the TDW as an entire set, a selected subset or a single ligand-protein complex and preserves all Chimera functionality.
AVAILABILITY AND IMPLEMENTATION: ViewDock TDW is an open source software; freely available on the web at http://www.tdw-prime.webs.com. Chimera UCSF is also available, free of charge, at http://www.cgl.ucsf.edu/chimera/

Mesh:

Substances:

Year:  2010        PMID: 20551133      PMCID: PMC2905552          DOI: 10.1093/bioinformatics/btq296

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  4 in total

1.  UCSF Chimera--a visualization system for exploratory research and analysis.

Authors:  Eric F Pettersen; Thomas D Goddard; Conrad C Huang; Gregory S Couch; Daniel M Greenblatt; Elaine C Meng; Thomas E Ferrin
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

Review 2.  Docking and scoring in virtual screening for drug discovery: methods and applications.

Authors:  Douglas B Kitchen; Hélène Decornez; John R Furr; Jürgen Bajorath
Journal:  Nat Rev Drug Discov       Date:  2004-11       Impact factor: 84.694

3.  ZINC--a free database of commercially available compounds for virtual screening.

Authors:  John J Irwin; Brian K Shoichet
Journal:  J Chem Inf Model       Date:  2005 Jan-Feb       Impact factor: 4.956

4.  Design of a grid service-based platform for in silico protein-ligand screenings.

Authors:  Marshall J Levesque; Kohei Ichikawa; Susumu Date; Jason H Haga
Journal:  Comput Methods Programs Biomed       Date:  2008-09-03       Impact factor: 5.428

  4 in total
  1 in total

1.  Characterization of Plasmodium Atg3-Atg8 Interaction Inhibitors Identifies Novel Alternative Mechanisms of Action in Toxoplasma gondii.

Authors:  Gustavo Arrizabalaga; William J Sullivan; Joseph M Varberg; Kaice A LaFavers
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.